Support for Location and Comprehension of User History in Collaborative Work

Users are being embraced as partners in developing computer services in many current computer supported cooperative work systems. Many web-based applications, including collaborative authoring tools like wikis, place users into collaborations with unknown and distant partners. Individual participants in such environments need to identify and understand others' contributions for collaboration to succeed and be efficient. One approach to supporting such understanding is to record user activity for later access. Issues with this approach include difficulties in locating activity of interest in large tasks and the history is often recorded at a system-activity level instead of at a human-activity level. To address these issues, this dissertation introduces CoActIVE, an application-independent history mechanism that clusters records of user activity and extracts keywords in an attempt to provide a human-level representation of history. CoActIVE is integrated in three different software applications to show its applicability and validity. Multiple visualization techniques based on this processing are compared in their ability to improve users' location and comprehension of the activity of others. The results show that filmstrip visualization and visual summarization of user activity show significant improvement over traditional list view interfaces. CoActIVE generates an interpretation of large-scale interaction history and provides the interpretation thorough a variety of visualizations that allow users to navigate the evolution of collaborative work. It supports branching history, with the understanding that asynchronous authoring and design tasks often involve the parallel development of alternatives. Additionally, CoActIVE has the potential to be integrated into a variety of applications with little adjustment for compatibility. Especially, the comparison of visualizations for locating and comprehending the work of others is unique

Non-Einstein Viscosity Phenomenon of Acrylonitrile–Butadiene–Styrene Composites Containing Lignin–Polycaprolactone Particulates Highly Dispersed by High-Shear Stress

Lignin powder was modified via ring-opening polymerization of caprolactone to form a lignin–polycaprolactone (LPCL) particulate. The LPCL particulates were mixed with an acrylonitrile–butadiene–styrene (ABS) matrix at an extremely high rotational speed of up to 3000 rpm, which was achieved by a closed-loop screw mixer and in-line melt extruder. Using this high-shear extruding mixer, the LPCL particulate size was controlled in the range of 3395 nm (conventional twin-screw extrusion) down to 638 nm (high-shear mixer of 3000 rpm) by altering the mixing speed and time. The resulting LPCL/ABS composites clearly showed non-Einstein viscosity phenomena, exhibiting reduced viscosity (2130 Pa·s) compared to the general extruded composite one (4270 Pa·s) at 1 s–1 and 210 °C. This is due to the conformational rearrangement and the increased free volume of ABS molecular chains in the vicinity of LPCL particulates. This was supported by the decreased glass transition temperature (Tg, 83.7 °C) of the LPCL/ABS composite specimens, for example, giving a 21.8% decrement compared to that (107 °C) of the neat ABS by the incorporation of 10 wt % LPCL particulates in ABS. The LPCL particulate morphology, damping characteristics, and light transmittance of the developed composites were thoroughly investigated at various levels of applied shear rates and mixing conditions. The non-Einstein rheological phenomena stemming from the incorporation of LPCL particulates suggest an interesting plasticization methodology: to improve the processability of high-loading filler/polymer composites and ultra-high molecular weight polymers that are difficult to process because of their high viscosity

Development of an Evaluation Methodology for Loss of Large Area induced from Extreme Events with malicious origin

Event of loss of large area (LOLA) induced from extreme external event at multi-units nuclear installation has been emerged a new challenges in the realm of nuclear safety and regulation after Fukushima Dai-Ichi accident. The relevant information and experience on evaluation methodology and regulatory requirements are rarely available and negative to share due to the security sensitivity. Most of countries has been prepared their own regulatory requirements and methodologies to evaluate impact of LOLA at nuclear power plant. In Korea, newly amended the Nuclear Safety Acts requires to assess LOLA in terms of EDMG (Extended Damage Mitigation Guideline). Korea Institute of Nuclear Safety (KINS) has performed a pilot research project to develop the methodology and regulatory review guidance on LOLA at multi-units nuclear power plant since 2014. Through this research, we proposed a methodology to identify the strategies for preventive and mitigation of the consequences of LOLA utilizing PSA techniques or its results. The proposed methodology is comprised of 8 steps including policy consideration, threat evaluation, identification of damage path sets, SSCs capacity evaluation and identification of mitigation measures and strategies. The consequence of LOLA due to malevolent aircraft crash may significantly susceptible with analysis assumptions including type of aircraft, amount of residual fuel, and hittable angle and so on, which cannot be shared overtly. This paper introduces a evaluation methodology for LOLA using PSA technique and its results. Also we provide a case study to evaluate hittable access angle using flight simulator for two types of aircrafts and to identify potential path sets leading to core damage by affected SSCs within damaged area

Two cases of pyogenic liver abscess due to Klebsiella pneumoniae in immunocompetent children

Pyogenic liver abscess (PLA) can be caused by bacteria entering the liver via the portal vein or primary bacteremia, or it can be cryptogenic. Recently, Klebsiella pneumoniae has been increasingly found as a PLA pathogen. PLA due to this bacterium often leads to formation of extrahepatic abscesses. The treatment of choice is dual therapy with insertion of percutaneous catheter drainage and antibiotic therapy. We report 2 cases of PLA due to K. pneumoniae in immunocompetent children. We successfully treated patient 1 with percutaneous catheter drainage for 18 days and 6-week course of antibiotic therapy. Patient 2 was treated with percutaneous needle aspiration and antibiotic therapy for the same period. In both patients, the PLAs showed the ultrasound-confirmed resolutions after the dual therapy

A multicenter phase II study of everolimus in patients with progressive unresectable adenoid cystic carcinoma

BACKGROUND: The aim of this study was to examine the efficacy and safety of everolimus in patients with progressive unresectable adenoid cystic carcinoma (ACC). METHODS: Histologically confirmed ACC patients with documented disease progression within 12 months prior to the study entry were eligible. Everolimus was given at a dose of 10 mg daily until progression or occurrence of unacceptable toxicities. The primary endpoint was a 4-month progression-free survival (PFS). RESULTS: A total of 34 patients were enrolled. The 4-month PFS probability was 65.5% (95% one-sided confidence interval [CI], 47.7 to infinity). Median PFS duration was 11.2 months (95% CI, 3.6 to 15.8). Complete or partial response was not achieved. Twenty-seven (79.4%, 95% CI, 63.2 to 89.6) patients showed stable disease (SD). Tumor shrinkage within SD criteria was observed in 15 patients (44.1%) and SD lasting 6 months was observed in 13 patients (38.2%). Four patients had disease progression. Among the 18 patients with both pre- and post-treatment (at 8 weeks) FDG-PET scans available, 8 patients (44.4%) showed a partial metabolic response, defined as a ≥25% reduction in maximum standardized uptake values (SUVmax). The most common adverse events were stomatitis, anemia, asthenia, and leukopenia. No unexpected everolimus related toxicities were reported. CONCLUSIONS: Everolimus showed promising efficacy and good tolerability in progressive unresectable ACC. TRIAL REGISTRATION: ClinicalTrials.gov identifier, NCT0115284

Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine

Despite growing interest and a recent surge in papers, the role of autophagy in glucose and lipid metabolism is unclear. We produced mice with skeletal muscle–specific deletion of Atg7 (encoding autophagy-related 7). Unexpectedly, these mice showed decreased fat mass and were protected from diet-induced obesity and insulin resistance; this phenotype was accompanied by increased fatty acid oxidation and browning of white adipose tissue (WAT) owing to induction of fibroblast growth factor 21 (Fgf21). Mitochondrial dysfunction induced by autophagy deficiency increased Fgf21 expression through induction of Atf4, a master regulator of the integrated stress response. Mitochondrial respiratory chain inhibitors also induced Fgf21 in an Atf4-dependent manner. We also observed induction of Fgf21, resistance to diet-induced obesity and amelioration of insulin resistance in mice with autophagy deficiency in the liver, another insulin target tissue. These findings suggest that autophagy deficiency and subsequent mitochondrial dysfunction promote Fgf21 expression, a hormone we consequently term a 'mitokine', and together these processes promote protection from diet-induced obesity and insulin resistance